Chicago Equity Partners LLC reduced its holdings in Colgate-Palmolive Company (NYSE:CL) by 3.6% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 128,015 shares of the company’s stock after selling 4,805 shares during the quarter. Chicago Equity Partners LLC’s holdings in Colgate-Palmolive were worth $9,490,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. American Beacon Advisors Inc. acquired a new stake in Colgate-Palmolive during the first quarter worth about $102,000. Proficio Capital Partners LLC grew its position in Colgate-Palmolive by 16.9% during the first quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock worth $107,000 after buying an additional 207 shares in the last quarter. OLD Second National Bank of Aurora acquired a new stake in Colgate-Palmolive during the second quarter worth about $109,000. Harbour Capital Advisors LLC acquired a new stake in Colgate-Palmolive during the first quarter worth about $121,000. Finally, Hanson & Doremus Investment Management grew its position in Colgate-Palmolive by 4.5% during the second quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock worth $121,000 after buying an additional 70 shares in the last quarter. 73.45% of the stock is currently owned by institutional investors and hedge funds.

A number of equities research analysts recently weighed in on CL shares. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Tuesday, September 26th. Jefferies Group LLC reissued a “hold” rating and set a $79.00 target price on shares of Colgate-Palmolive in a research report on Thursday, September 28th. Morgan Stanley decreased their target price on Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating on the stock in a research report on Tuesday. KeyCorp reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Monday, October 16th. Finally, Macquarie started coverage on Colgate-Palmolive in a research report on Thursday, September 14th. They set a “neutral” rating and a $76.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $76.67.

In other Colgate-Palmolive news, Vice Chairman Franck J. Moison sold 35,000 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $71.52, for a total value of $2,503,200.00. Following the sale, the insider now owns 201,411 shares in the company, valued at $14,404,914.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Patricia Verduin sold 3,833 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $71.45, for a total transaction of $273,867.85. Following the completion of the sale, the insider now owns 53,173 shares in the company, valued at approximately $3,799,210.85. The disclosure for this sale can be found here. Insiders have sold a total of 52,833 shares of company stock worth $3,776,108 in the last quarter. 1.02% of the stock is currently owned by company insiders.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The original version of this piece of content can be accessed at https://www.watchlistnews.com/colgate-palmolive-company-cl-shares-sold-by-chicago-equity-partners-llc/1674761.html.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. The business had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The firm’s revenue for the quarter was up 2.8% on a year-over-year basis. During the same quarter last year, the business posted $0.73 EPS.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Investors of record on Monday, October 23rd will be given a dividend of $0.40 per share. The ex-dividend date is Friday, October 20th. This represents a $1.60 annualized dividend and a dividend yield of 2.26%. Colgate-Palmolive’s dividend payout ratio is 61.78%.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.